Ghetie V - Search Results

1

Design and In Vivo Characterization of Immunoconjugates Targeting HIV gp160.

Pincus SH, Song K, Maresh GA, Frank A, Worthylake D, Chung HK, Polacino P, Hamer DH, Coyne CP, Rosenblum MG, Marks JW, Chen G, Weiss D, Ghetie V, Vitetta ES, Robinson JE, Hu SL. Pincus SH, et al. Among authors: ghetie v. J Virol. 2017 Jan 18;91(3):e01360-16. doi: 10.1128/JVI.01360-16. Print 2017 Feb 1. J Virol. 2017. PMID: 27795412 Free PMC article.

2

Identification of Human Anti-HIV gp160 Monoclonal Antibodies That Make Effective Immunotoxins.

Pincus SH, Song K, Maresh GA, Hamer DH, Dimitrov DS, Chen W, Zhang MY, Ghetie VF, Chan-Hui PY, Robinson JE, Vitetta ES. Pincus SH, et al. Among authors: ghetie vf. J Virol. 2017 Jan 18;91(3):e01955-16. doi: 10.1128/JVI.01955-16. Print 2017 Feb 1. J Virol. 2017. PMID: 27852851 Free PMC article.

3

Chemical construction of immunotoxins.

Ghetie V, Vitetta ES. Ghetie V, et al. Methods Mol Med. 2000;25:1-26. doi: 10.1385/1-59259-075-6:1. Methods Mol Med. 2000. PMID: 21318837

4

Immunotoxins in the therapy of cancer: from bench to clinic.

Ghetie V, Vitetta E. Ghetie V, et al. Pharmacol Ther. 1994 Sep;63(3):209-34. doi: 10.1016/0163-7258(94)90025-6. Pharmacol Ther. 1994. PMID: 7831391 Review.

5

The in vivo anti-tumor activity of immunotoxins containing two versus one deglycosylated ricin A chains.

Ghetie V, Engert A, Schnell R, Vitetta ES. Ghetie V, et al. Cancer Lett. 1995 Nov 27;98(1):97-101. Cancer Lett. 1995. PMID: 8529213

6

Immunology. Considering therapeutic antibodies.

Vitetta ES, Ghetie VF. Vitetta ES, et al. Among authors: ghetie vf. Science. 2006 Jul 21;313(5785):308-9. doi: 10.1126/science.1130482. Science. 2006. PMID: 16857927 No abstract available.

7

The generation of immunotoxins using chimeric anti-CD22 antibodies containing mutations which alter their serum half-life.

Pop LM, Liu X, Ghetie V, Vitetta ES. Pop LM, et al. Among authors: ghetie v. Int Immunopharmacol. 2005 Jul;5(7-8):1279-90. doi: 10.1016/j.intimp.2005.03.013. Epub 2005 Apr 26. Int Immunopharmacol. 2005. PMID: 15914332

8

Immunotoxins for the treatment of B-cell lymphomas.

Ghetie MA, Ghetie V, Vitetta ES. Ghetie MA, et al. Among authors: ghetie v. Mol Med. 1997 Jul;3(7):420-7. Mol Med. 1997. PMID: 9260154 Free PMC article. Review. No abstract available.

9

Anti-CD19 antibodies inhibit the function of the P-gp pump in multidrug-resistant B lymphoma cells.

Ghetie MA, Ghetie V, Vitetta ES. Ghetie MA, et al. Among authors: ghetie v. Clin Cancer Res. 1999 Dec;5(12):3920-7. Clin Cancer Res. 1999. PMID: 10632321

10

Chemical construction of immunotoxins.

Ghetie V, Vitetta ES. Ghetie V, et al. Mol Biotechnol. 2001 Jul;18(3):251-68. doi: 10.1385/MB:18:3:251. Mol Biotechnol. 2001. PMID: 11503519 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

146 results

Search Page